In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
The COVID-19 pandemic has caused severe health threat globally, and novel SARS-Cov-2 inhibitors are urgently needed for antiviral treatment. The main protease (M<sup>pro</sup>) of the virus is one of the most effective and conserved targets for anti-SARS-CoV-2 drug development. In this s...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-07-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/28/14/5320 |